Search research articles
Contact Us
Filters
Showing results (81-90 of 138) with videos related to
Page
of 14
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
April 3, 2007
[Long-term results and prognostic factors of squamous cell carcinoma of the anal canal treated by irradiation]
L Tournier-Rangeard, D Peiffert, C Lafond, et al.
The Journal of Infusional Chemotherapy
|
January 1, 1995
Randomized trial comparing conventional intravenous bolus FEC and FEC with high-dose infusional 5-fluorouracil as first-line treatment of advanced breast cancer
M Hebbar, J Bonneterre, C Fournier, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
March 14, 2008
Validation of the French version of the colorectal-specific quality-of-life questionnaires EORTC QLQ-CR38 and FACT-C
Christine Rotonda, T Conroy, M Mercier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 3, 2001
High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study
D Peiffert, M Giovannini, M Ducreux, et al.
Oncology
|
March 2, 2011
Cost-minimisation analysis in first-line treatment of metastatic colorectal cancer in France: XELOX versus FOLFOX-6
G Perrocheau, J Bennouna, M Ducreux, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
March 3, 2012
Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study
T S Dabakuyo, F Guillemin, T Conroy, et al.
British Journal of Cancer
|
November 19, 2009
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer
T Conroy, M Hebbar, J Bennouna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1991
Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group
J A Wils, H O Klein, D J Wagener, et al.
British Journal of Cancer
|
October 9, 2008
Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer
T Conroy, F Viret, E François, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2003
Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer
J M Blazeby, T Conroy, E Hammerlid, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 138) with videos related to
Sort By:
Page
of 14
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
April 3, 2007
[Long-term results and prognostic factors of squamous cell carcinoma of the anal canal treated by irradiation]
L Tournier-Rangeard, D Peiffert, C Lafond, et al.
The Journal of Infusional Chemotherapy
|
January 1, 1995
Randomized trial comparing conventional intravenous bolus FEC and FEC with high-dose infusional 5-fluorouracil as first-line treatment of advanced breast cancer
M Hebbar, J Bonneterre, C Fournier, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
March 14, 2008
Validation of the French version of the colorectal-specific quality-of-life questionnaires EORTC QLQ-CR38 and FACT-C
Christine Rotonda, T Conroy, M Mercier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 3, 2001
High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study
D Peiffert, M Giovannini, M Ducreux, et al.
Oncology
|
March 2, 2011
Cost-minimisation analysis in first-line treatment of metastatic colorectal cancer in France: XELOX versus FOLFOX-6
G Perrocheau, J Bennouna, M Ducreux, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
March 3, 2012
Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study
T S Dabakuyo, F Guillemin, T Conroy, et al.
British Journal of Cancer
|
November 19, 2009
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer
T Conroy, M Hebbar, J Bennouna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1991
Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group
J A Wils, H O Klein, D J Wagener, et al.
British Journal of Cancer
|
October 9, 2008
Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer
T Conroy, F Viret, E François, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2003
Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer
J M Blazeby, T Conroy, E Hammerlid, et al.
Page
of 14